Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,431 shares at $700.00 ($1.7M) on 2022-03-30, disclosed to the SEC on 2022-04-01.
Open-market sale of $1.7M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |
| REGN | SELL | 2020-10-06 | $5.5M | — | Filing → |